Haemoglobin decreased: FDA reporting patterns
101,524 FDA FAERS reports mention Haemoglobin decreased. 89,429 reports have a serious outcome flag.
Medicines named as suspect
- Lenalidomide: 5,327 reports
- Eculizumab: 4,044 reports
- Ribavirin: 4,003 reports
- Ruxolitinib: 3,642 reports
- Clozapine: 3,267 reports
- Adalimumab: 3,080 reports
- Aspirin: 2,923 reports
- Rivaroxaban: 2,403 reports
- Rituximab: 2,314 reports
- Methotrexate: 2,124 reports
- Warfarin: 2,082 reports
- Peginterferon Alfa-2a: 1,948 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.